# Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

> **NCT00654498** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 306 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00654498
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654498, "Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00654498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*